Literature DB >> 8300707

Trans-osseous ilio-femoral by-pass. A new extra-anatomical by-pass.

J P Favre1, J P Gournier, X Barral.   

Abstract

A new extra-anatomical by-pass is described as an alternative procedure to solve complicated vascular problems in the groin. This trans-osseous ilio-femoral by-pass can be use in spite of classical extra-anatomical by-passes (obturator, perineal, supra-pubic, axillo-femoral). The proximal anastomosis can be performed on aorto-iliac homolateral axis by a retro-peritoneal approach. The by-pass is going externally on the psoas-iliac muscle, through the iliac aisle and then between the sartorius and gluteus medius muscle. Distal anastomosis can be performed on the profunda femoral artery or, with sequential by-pass, on multiple arteries of the leg. We have performed such a by-pass in 5 patients for femoral triangle infection (4 cases) or radiotherapeutic complication. One patient died after cardiac surgery, another has had a major amputation. Three by-passes are patent with a follow-up period of 2 years. This by-pass is easy to do, its route is short, deep (without neurological, bleeding or compressive risk) and far from an eventual infected common femoral artery.

Entities:  

Mesh:

Year:  1993        PMID: 8300707

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Management of vascular infection in the groin.

Authors:  Cagatay Engin; Hakan Posacioglu; Fatih Ayik; Anil Ziya Apaydin
Journal:  Tex Heart Inst J       Date:  2005

2.  Long-Term Results of Obturator Bypass.

Authors:  Hisao Masaki; Atsushi Tabuchi; Yasuhiro Yunoki; Noriaki Kuwata; Taishi Tamura; Takeshi Honda; Hiroki Takiuchi; Takahiko Yamasawa; Hiroshi Furukawa; Masahiko Kuinose; Kazuo Tanemoto; Yoshiko Watanabe
Journal:  Ann Vasc Dis       Date:  2016-03-11

3.  Trans-iliac Bypass for Critical Limb Ischaemia with Groin Necrosis: A Case Report.

Authors:  Youcef Lounes; Baris A Ozdemir; Pierre Alric; Ludovic Canaud
Journal:  EJVES Short Rep       Date:  2019-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.